PNC Financial Services Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Buy |
1,952
+294
| +18% | +$15.7K | ﹤0.01% | 2685 |
|
|
2025
Q1 | $67.1K | Buy |
1,658
+390
| +31% | +$15.8K | ﹤0.01% | 2925 |
|
|
2024
Q4 | $35.3K | Sell |
1,268
-9
| -0.7% | -$250 | ﹤0.01% | 3281 |
|
|
2024
Q3 | $36.6K | Buy |
1,277
+10
| +0.8% | +$287 | ﹤0.01% | 3238 |
|
|
2024
Q2 | $29.7K | Sell |
1,267
-23
| -2% | -$540 | ﹤0.01% | 3292 |
|
|
2024
Q1 | $32.6K | Buy |
1,290
+1,229
| +2,015% | +$31K | ﹤0.01% | 3199 |
|
|
2023
Q4 | $1.42K | Sell |
61
-70
| -53% | -$1.63K | ﹤0.01% | 4246 |
|
|
2023
Q3 | $6.63K | Buy |
131
+88
| +205% | +$4.45K | ﹤0.01% | 3906 |
|
|
2023
Q2 | $2.01K | Buy |
43
+28
| +187% | +$1.31K | ﹤0.01% | 4380 |
|
|
2023
Q1 | $574 | Hold |
15
| – | – | ﹤0.01% | 4512 |
|
|
2022
Q4 | $822 | Hold |
15
| – | – | ﹤0.01% | 4445 |
|
|
2022
Q3 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 4278 |
|